HomeCompareEXC vs BAX

EXC vs BAX: Dividend Comparison 2026

EXC yields 3.30% · BAX yields 2.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EXC wins by $5.6K in total portfolio value
10 years
EXC
EXC
● Live price
3.30%
Share price
$49.11
Annual div
$1.62
5Y div CAGR
4.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.2K
Annual income
$671.89
Full EXC calculator →
BAX
BAX
● Live price
2.28%
Share price
$15.80
Annual div
$0.36
5Y div CAGR
-27%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$10.26
Full BAX calculator →

Portfolio growth — EXC vs BAX

📍 EXC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEXCBAX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EXC + BAX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EXC pays
BAX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EXC
Annual income on $10K today (after 15% tax)
$280.39/yr
After 10yr DRIP, annual income (after tax)
$571.11/yr
BAX
Annual income on $10K today (after 15% tax)
$193.67/yr
After 10yr DRIP, annual income (after tax)
$8.72/yr
At 15% tax rate, EXC beats the other by $562.39/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EXC + BAX for your $10,000?

EXC: 50%BAX: 50%
100% BAX50/50100% EXC
Portfolio after 10yr
$23.4K
Annual income
$341.07/yr
Blended yield
1.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EXC right now

EXC
Analyst Ratings
17
Buy
16
Hold
2
Sell
Consensus: Buy
Price Target
$50.55
+2.9% upside vs current
Range: $39.00 — $57.00
Altman Z
0.8
Piotroski
5/9
BAX
Analyst Ratings
15
Buy
20
Hold
1
Sell
Consensus: Hold
Price Target
$19.75
+25.0% upside vs current
Range: $15.00 — $25.00
Altman Z
2.1
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EXC buys
0
BAX buys
0
No recent congressional trades found for EXC or BAX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEXCBAX
Forward yield3.30%2.28%
Annual dividend / share$1.62$0.36
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR4.6%-27%
Portfolio after 10y$26.2K$20.6K
Annual income after 10y$671.89$10.26
Total dividends collected$4.9K$602.00
Payment frequencyquarterlyquarterly
SectorUtilitiesHealthcare
Analyst consensusBuyHold
Analyst price target$50.55$19.75

Year-by-year: EXC vs BAX ($10,000, DRIP)

YearEXC PortfolioEXC Income/yrBAX PortfolioBAX Income/yrGap
1← crossover$11,045$345.05$10,866$166.33+$179.00EXC
2$12,191$372.56$11,750$123.31+$441.00EXC
3$13,446$401.98$12,664$90.97+$782.00EXC
4$14,821$433.43$13,617$66.89+$1.2KEXC
5$16,325$467.02$14,619$49.07+$1.7KEXC
6$17,971$502.89$15,679$35.94+$2.3KEXC
7$19,770$541.17$16,802$26.30+$3.0KEXC
8$21,736$581.99$17,998$19.23+$3.7KEXC
9$23,883$625.51$19,272$14.05+$4.6KEXC
10$26,227$671.89$20,631$10.26+$5.6KEXC

EXC vs BAX: Complete Analysis 2026

EXCUtilities

Exelon Corporation, a utility services holding company, engages in the energy generation, delivery, and marketing businesses in the United States and Canada. It owns nuclear, fossil, wind, hydroelectric, biomass, and solar generating facilities. The company also sells electricity to wholesale and retail customers; and sells natural gas, renewable energy, and other energy-related products and services. Additionally, it is involved in the purchase and regulated retail sale of electricity and natural gas; and transmission and distribution of electricity, and distribution of natural gas to retail customers. Further, the company offers support services, including legal, human resources, information technology, financial, supply management, accounting, engineering, customer operations, distribution and transmission planning, asset management, system operations, and power procurement services. It serves distribution utilities, municipalities, cooperatives, and financial institutions, as well as commercial, industrial, governmental, and residential customers. Exelon Corporation was incorporated in 1999 and is headquartered in Chicago, Illinois.

Full EXC Calculator →

BAXHealthcare

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Full BAX Calculator →
📬

Get this EXC vs BAX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EXC vs SCHDEXC vs JEPIEXC vs OEXC vs KOEXC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.